The studies – The clinical trials

We perform clinical assessment (clinical trials) in the field of neurology. Patient recruitment is provided from our patient database. Our health professionals have extensive experience with studies as investigators and as principal investigators.

The experience of our physicians with clinical trials.

The experience of our physicians with clinical trials

Schwarz Pharma	Rotigotine	phase III	Parkinson disease	2005-2007
Merz	Botulinum toxin A	phase III	post stroke spasticity	2006-2007
Allergan	Botulinum toxin A	phase III	Cervical dystonia	2007-2008
Novartis	Fingolimod	phase III	Sclerosis multiplex	2009-2014
Merz	Botulinum toxin A	phase III	post stroke spasticity	2010-2013
Ipsen	Botulinum toxin A	phase III	Cervical dystonia	2011-2013
Allergan	Botulinum toxin A	phase III	post stroke spasticity	2012-2015
Astra Zeneca	Ticagrelor/Aspirin	phase III	Stroke	2013- 2016
Novartis	Fingolimod	phase III	Sclerosis multiplex	2014-2015
Merz	Botulinum toxin A	phase III	Cerebral palsy	2014-2017
Ipsen	Botulinum toxin A	phase III	Cerebral palsy	2014-2017
Ipsen	Botulinum toxin A	phase III	post stroke spasticity	2017-2018
Alder	CGRP	phase III	Chronic Migraine	2017-2018
Novartis	Angiotensin II type 2 receptor	phase II	Post-herpetic neuralgia	2018-2019
Biogen	Inhibitor of voltage-gated sodium channels	phase II	Small fibre neuropathy	2018-2022
Merz	Botulinum toxin A	phase III	Spasticity (stroke, brain injury)	2019-Present
Algiax	AP-325 (malononitrilamid)	phase II	Peripheral postsurgical neuropatic pain	2020-Present

Olainfarm	Neiromidin	phase III	Lumbosacral radiculopathy	2021-2022
Janssen R.aD.	Nipocalimab	phase III	Myastenia Gravis	2021-Present
Labor.Lesvi, S.L.	Pregabalin	phase III	Peripheral neuropathic pain	2022-2024

If you are interested, please contact us, preferably by email:    neurologiezidlochovice@seznam.cz  

Please include “Dr. Eduard Minks” in the subject line of the email.

Telephone number: 00 420 730 415 109

Eduard Minks, MD, Ph.D.